Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect on Contrast Induced Acute Kidney Injury of APX-115 in Subjects Undergoing Percutaneous Coronary Intervention A Randomized, Double-blind, Parallel Group, Multicenter, Multi-national Trial

NCT05758896 is registered in ClinicalTrials.gov with Aptabio Therapeutics, Inc. as lead sponsor.

NCT NCT05758896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05758896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect on Contrast Induced Acute Kidney Injury of APX-115 in Subjects Undergoing Percutaneous Coronary Intervention A Randomized, Double-blind, Parallel Group, Multicenter, Multi-national Trial
Lead sponsor
Aptabio Therapeutics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
December 27, 2023
Completion date
July 22, 2026
Enrollment
218 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

contrast induced acute kidney injury